Year-Long trial tests new hope for schizophrenia management
NCT ID NCT07225712
Summary
This study aims to see how safe and effective a new investigational drug called SEP-363856 is when taken for a full year by adults with stable schizophrenia. It will involve about 100 participants who will take the medication daily. The main goal is to monitor for any side effects and see how well the drug helps control symptoms over the long term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Jimbo Kokorono Clinic
RECRUITINGFukuoka, Japan
Conditions
Explore the condition pages connected to this study.